Log In
Print
BCIQ
Print
Print this Print this
 

orantinib (TSU-68)

  Manage Alerts
Collapse Summary General Information
Company Taiho Pharmaceutical Co. Ltd.
DescriptionLow-molecular-weight anti-angiogenetic agent that inhibits receptor tyrosine kinase
Molecular Target Tyrosine kinase receptor 1 (Tie1)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today